MUHAMMAD NAWAZ: Open Payments
NPI 1750850863 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 16 payments from 9 companies in 2025. Trend: 2023 $1,107 · 2024 $1,016 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $200 |
| Axsome Therapeutics, Inc. | 3 | $152 |
| Alkermes, Inc. | 2 | $142 |
| Braeburn Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $119 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, Auvelity, BRIXADI, LYBALVI, UZEDY, FANAPT, ARISTADA, REXULTI.
Industry payments across FL — which companies pay providers there.
